# Initial Case Report of Robot‐Assisted Radical Cystectomy With Intracorporeal Neobladder Using hinotori Surgical Robot System

## TL;DR

This paper reports the first case of robot-assisted bladder cancer surgery using the hinotori robot, showing successful outcomes and recovery.

## Contribution

The first reported use of the hinotori surgical robot for intracorporeal neobladder construction during RARC.

## Key findings

- The surgery was completed without complications in 430 minutes with no blood transfusion needed.
- The patient was discharged on day 12 and achieved satisfactory continence post-surgery.
- This case suggests hinotori is a viable alternative to existing robotic systems for RARC.

## Abstract

Robot‐assisted radical cystectomy (RARC) is becoming the standard treatment for bladder cancer patients. While this surgery using da Vinci has been widely reported, this report describes the initial experience of RARC with intracorporeal neobladder using the hinotori surgical robot system.

The patient was a 73‐year‐old man with muscle‐invasive bladder cancer who underwent neoadjuvant chemotherapy followed by RARC with intracorporeal neobladder using hinotori. Surgery was successfully performed with a total operative time of 430 min, time using the robotic system of 375 min, and no intraoperative complications or need for blood transfusion. Postoperative recovery was favorable, with the patient discharged on day 12, and satisfactory continence was achieved.

This is the initial case report of RARC with intracorporeal neobladder using hinotori, providing a potentially comparable alternative to conventional surgical systems for RARC.